358 related articles for article (PubMed ID: 21704372)
1. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
[TBL] [Abstract][Full Text] [Related]
2. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.
Buckstein R; Jang K; Friedlich J; Zhang L; Reis M; Chesney A; Wells RA
Leuk Res; 2009 Oct; 33(10):1313-8. PubMed ID: 19282029
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility.
Klco JM; Geng B; Brunt EM; Hassan A; Nguyen TD; Kreisel FH; Lisker-Melman M; Frater JL
Am J Hematol; 2010 Feb; 85(2):106-10. PubMed ID: 20095034
[TBL] [Abstract][Full Text] [Related]
4. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
5. Unexplained macrocytosis.
Younes M; Dagher GA; Dulanto JV; Njeim M; Kuriakose P
South Med J; 2013 Feb; 106(2):121-5. PubMed ID: 23380746
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia.
Yamauchi T; Matsuda Y; Takai M; Tasaki T; Hosono N; Negoro E; Ikegaya S; Takagi K; Kishi S; Yoshida A; Urasaki Y; Ueda T
Anticancer Res; 2012 Oct; 32(10):4479-83. PubMed ID: 23060576
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes.
Foran JM; Shammo JM
Am J Med; 2012 Jul; 125(7 Suppl):S6-13. PubMed ID: 22735753
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndrome.
Hofmann WK; Koeffler HP
Annu Rev Med; 2005; 56():1-16. PubMed ID: 15660498
[TBL] [Abstract][Full Text] [Related]
11. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
13. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
[TBL] [Abstract][Full Text] [Related]
14. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
Kao JM; McMillan A; Greenberg PL
Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
[TBL] [Abstract][Full Text] [Related]
15. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
16. Refractory anemia and the myelodysplastic syndromes.
Lawrence LW
Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
[TBL] [Abstract][Full Text] [Related]
17. [Immunologic phenomena as the first sign of myelodysplastic syndrome].
van Rijn RS; Wittebol S; Graafland AD; Kramer MH
Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1529-33. PubMed ID: 11525083
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of bicytopenia and pancytopenia during pregnancy].
Zhang C; Liang MY; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):488-91. PubMed ID: 19957545
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
20. Unexplained macrocytosis in elderly patients.
Mahmoud MY; Lugon M; Anderson CC
Age Ageing; 1996 Jul; 25(4):310-2. PubMed ID: 8831877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]